Upload
Featured Recent Articles Topics Login Upload

Search Results for 'refractory relapsed'

refractory relapsed published presentations and documents on DocSlides.

The Biology of Relapsed and Refractory Multiple Myeloma
The Biology of Relapsed and Refractory Multiple Myeloma
by alexa-scheidler
Topics. Current Treatment Options for Relapsed/Re...
Relapsed and Refractory Myeloma
Relapsed and Refractory Myeloma
by jane-oiler
Ruben Niesvizky. Myeloma Center. Myelomacenter.or...
Future directions: Can we improve outcomes in relapsed/refractory DLBCL or aggressive NHL?
Future directions: Can we improve outcomes in relapsed/refractory DLBCL or aggressive NHL?
by mitsue-stanley
Bertrand Coiffier. Service d. ’. Hématologie. ...
Improving Therapy Outcomes in Relapsed/Refractory
Improving Therapy Outcomes in Relapsed/Refractory
by celsa-spraggs
Hodgkin Lymphoma. Program Objectives. Brentuximab...
Recurrent HL after Auto
Recurrent HL after Auto
by karlyn-bohler
T. ransplant . in CR on . B. rentuximab. . V. ed...
Relapsed or Relapsed/Refractory
Relapsed or Relapsed/Refractory
by alexa-scheidler
5 Multiple Myeloma SANDRA E. KURTIN, RN, MS, AOCN
x0000x0000 xAttxachexd xBottxom xBBoxx
x0000x0000 xAttxachexd xBottxom xBBoxx
by evans
Chimeric Antigen Receptor Tcell TherapyClinical Gu...
Case Discussion A 64-year old woman diagnosed with monoclonal
Case Discussion A 64-year old woman diagnosed with monoclonal
by faustina-dinatale
Case Discussion A 64-year old woman diagnosed wit...
Pomalidomide
Pomalidomide
by marina-yarberry
therapy in relapsed/refractory myeloma: . A UK m...
Brentuximab Vedotin.
Brentuximab Vedotin.
by luanne-stotts
How and When Should it be Used in B and T cell Ly...
Personalized Therapy in Relapsed or Refractory CLL
Personalized Therapy in Relapsed or Refractory CLL
by kittie-lecroy
IWCLL Criteria for Treating CLL. Other Considerat...
Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
by conchita-marotz
ASH Review 2012. Stephen Spurgeon (spurgeos@ohsu....
Relapsed/Refractory Follicular Lymphoma Conundrums
Relapsed/Refractory Follicular Lymphoma Conundrums
by danika-pritchard
This program will include a discussion of off-lab...
Please note, these are the
Please note, these are the
by ryotheasy
actual. . video-recorded proceedings from the . l...
Pivotal Safety and Efficacy Results From TRANSCEND NHL 001, a Multicenter Phase 1 Study of Lisocabtagene Maraleucel in Relapsed/Refractory (R/R) Large B-Cell Lymphomas
Pivotal Safety and Efficacy Results From TRANSCEND NHL 001, a Multicenter Phase 1 Study of Lisocabtagene Maraleucel in Relapsed/Refractory (R/R) Large B-Cell Lymphomas
by botgreat
Lisocabtagene. . Maraleucel. in Relapsed/Refract...
CAR-T Therapy in non-Hodgkin lymphomas
CAR-T Therapy in non-Hodgkin lymphomas
by natalie
Jonathon B. Cohen, MD. Dept of . Hematology. /Medi...
Understanding Lymphoma Series
Understanding Lymphoma Series
by evans
Helpline: 800 500 9976 | helpline@lymphoma.org U...
Carfilzomib, Dexamethasone, and Daratumumab Versus Carfilzomib and Dexamethasone in Relapsed or Ref
Carfilzomib, Dexamethasone, and Daratumumab Versus Carfilzomib and Dexamethasone in Relapsed or Ref
by willow
Meletios Dimopoulos,. 1. Hang Quach,. 2. Maria-V...
Aktuelle Therapieempfehlungen beim Multiplen
Aktuelle Therapieempfehlungen beim Multiplen
by brown
Myelom. Heinz . Gisslinger. Medizinische Universit...
AFM13 in Combination with Allogeneic Natural Killer Cells (AB-101) in Relapsed or Refractory Hodgki
AFM13 in Combination with Allogeneic Natural Killer Cells (AB-101) in Relapsed or Refractory Hodgki
by cesar673
+. Peripheral T-Cell Lymphoma: A Phase 2 Study (L...